| Dr. Brian R. Pettie Eyecare, Pc | |
|
9248 Parkway E, Birmingham, AL 35206-1509 | |
| (205) 833-3171 | |
| (205) 833-3059 |
| Full Name | Dr. Brian R. Pettie Eyecare, Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 9248 Parkway E, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215135967 | NPI | - | NPPES |
| 51532635 | Other | AL | BCBS AL IRONDALE LOCATION |
| U99431 | Other | AL | VIVA |
| 51538863 | Other | AL | BCBS AL ROEBUCK LOCATION |
| U99431 | Other | AL | VIVA MEDICARE PLUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S-A54-TA-634 (Alabama) | Primary |
| Provider Name | Brian R Pettie |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1891802120 PECOS PAC ID: 3274515606 Enrollment ID: I20040601001027 |
News Archive
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress. Results of the study are published in Neurogastroenterology & Motility.
Scientists seeking to regrow damaged kidneys have discovered that blocked kidneys in newborns have a remarkable ability to repair themselves after the obstruction is removed.
Healthcare-associated infections are the fourth leading cause of death in Canada, predicted to move up to second place by 2050.
Childhood overweight and obesity are serious, large-scale, global, public health concerns and the number of children affected is still increasing every year. As the treatment of overweight and obesity is rarely effective, its prevention has priority today.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 6 days ago
| Provider Name | Parisa T Dudley |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063505097 PECOS PAC ID: 8224091285 Enrollment ID: I20041110000619 |
News Archive
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress. Results of the study are published in Neurogastroenterology & Motility.
Scientists seeking to regrow damaged kidneys have discovered that blocked kidneys in newborns have a remarkable ability to repair themselves after the obstruction is removed.
Healthcare-associated infections are the fourth leading cause of death in Canada, predicted to move up to second place by 2050.
Childhood overweight and obesity are serious, large-scale, global, public health concerns and the number of children affected is still increasing every year. As the treatment of overweight and obesity is rarely effective, its prevention has priority today.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 6 days ago
| Provider Name | Jennifer M Craig |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831537356 PECOS PAC ID: 2062646326 Enrollment ID: I20130930000316 |
News Archive
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress. Results of the study are published in Neurogastroenterology & Motility.
Scientists seeking to regrow damaged kidneys have discovered that blocked kidneys in newborns have a remarkable ability to repair themselves after the obstruction is removed.
Healthcare-associated infections are the fourth leading cause of death in Canada, predicted to move up to second place by 2050.
Childhood overweight and obesity are serious, large-scale, global, public health concerns and the number of children affected is still increasing every year. As the treatment of overweight and obesity is rarely effective, its prevention has priority today.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr. Brian R. Pettie Eyecare, Pc 9248 Parkway E, Birmingham, AL 35206-1509 Ph: (205) 833-3171 | Dr. Brian R. Pettie Eyecare, Pc 9248 Parkway E, Birmingham, AL 35206-1509 Ph: (205) 833-3171 |
News Archive
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress. Results of the study are published in Neurogastroenterology & Motility.
Scientists seeking to regrow damaged kidneys have discovered that blocked kidneys in newborns have a remarkable ability to repair themselves after the obstruction is removed.
Healthcare-associated infections are the fourth leading cause of death in Canada, predicted to move up to second place by 2050.
Childhood overweight and obesity are serious, large-scale, global, public health concerns and the number of children affected is still increasing every year. As the treatment of overweight and obesity is rarely effective, its prevention has priority today.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 6 days ago
Elise Debruler Agostinelli, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1720 University Blvd, Birmingham, AL 35233 Phone: 205-488-0736 | |
Dr. Elizabeth Steele, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1716 University Blvd, Hpb G080a, Birmingham, AL 35294 Phone: 205-975-2020 Fax: 205-934-6755 | |
Dr. Albert C. Snyder, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1716 University Blvd, Hbp Building, Birmingham, AL 35294 Phone: 205-975-9827 Fax: 205-975-8281 | |
Paul Dennis Batson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 250 State Farm Pkwy, Birmingham, AL 35209 Phone: 205-943-4600 Fax: 205-943-4660 | |
Jsd Eyecare, L.l.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9248 Parkway E, Birmingham, AL 35206 Phone: 205-833-3171 Fax: 205-833-3059 | |
Margaret Kathleen Bailey, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1716 University Blvd G080a, Birmingham, AL 35294 Phone: 205-975-2020 Fax: 205-934-6755 | |
Kristy Y-van Nguyen, Optometrist Medicare: Medicare Enrolled Practice Location: 1716 University Blvd G080a, Birmingham, AL 35294 Phone: 205-975-2020 Fax: 205-934-6755 |